Evidence map›Paper›PMID 40040820›Full record

ArticleLancet regional health. Americas2025

Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group.

Michael Gottlieb, Huihui Yu, Ji Chen, Erica S Spatz, Nicole L Gentile, Rachel E Geyer, Michelle Santangelo, Caitlin Malicki, Kristyn Gatling, Sharon Saydah and 14 more

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Vascular inflammation in neuropsychiatric long COVID.Brain, behavior, & immunity - health · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Living With Persistent Respiratory Symptoms of Long COVID: Qualitative Study Among Brazilian Adults 12 Months After Acute Infection.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  14. From Stagnation to Strategy: Challenges in Advancing Long COVID Research.Journal of evaluation in clinical practice · 2025
    Review
  15. Article
  16. Article
  17. B Cell Dynamics and Transitional B Cells in Long COVID.Current issues in molecular biology · 2025
    Article
  18. Review
  19. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Michael GottliebDepartment of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
Huihui YuSection of Cardiovascular Medicine, Yale School of Medicine New Haven, CT, USA.
Ji ChenSection of Cardiovascular Medicine, Yale School of Medicine New Haven, CT, USA.
Erica S SpatzSection of Cardiovascular Medicine, Yale School of Medicine New Haven, CT, USA.
Nicole L GentileDepartment of Family Medicine, University of Washington, Seattle, WA, USA.
Rachel E GeyerDepartment of Family Medicine, University of Washington, Seattle, WA, USA.
Michelle SantangeloDepartment of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
Caitlin MalickiDepartment of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
Kristyn GatlingDivision of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
Sharon SaydahNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA, USA.
Kelli N O'LaughlinDepartments of Emergency Medicine and Global Health, University of Washington, Seattle, WA, USA.
Kari A StephensDepartment of Family Medicine, University of Washington, Seattle, WA, USA.
Joann G ElmoreDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, USA.
Lauren E WiskDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, USA.
Michelle L'HommedieuDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, USA.
Robert M RodriguezDepartment of Emergency Medicine, University of California, San Francisco, CA, USA.
Juan Carlos C MontoyDepartment of Emergency Medicine, University of California, San Francisco, CA, USA.
Ralph C WangDepartment of Emergency Medicine, University of California, San Francisco, CA, USA.
Kristin L RisingDepartment of Emergency Medicine, Sidney Kimmel Medical College, Philadelphia, PA, USA.
Efrat KeanDepartment of Emergency Medicine, Sidney Kimmel Medical College, Philadelphia, PA, USA.
Jonathan W DyalDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, USA.
Mandy J HillDepartment of Emergency Medicine, McGovern Medical School at UTHealth Houston, USA.
Arjun K VenkateshYale Center for Outcomes Research and Evaluation, New Haven, CT, USA.
Robert A WeinsteinDivision of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Background: Although short-term outcomes of Long COVID have been described, longer-term physical and mental health outcomes of Long COVID are less well-established. This study sought to assess differences in long-term physical and mental health outcomes extending up to three years among those with current, resolved, and no Long COVID, as well as duration of Long COVID and vaccination status. Methods: This was a prospective, multisite, study of participants with SARS-CoV-2 infection from 12/7/2020-8/29/2022, with data collected through 4/2/2024. Surveys included validated tools for physical and mental health. Data were analyzed by Long COVID status (never-had, resolved, current), Long COVID duration and vaccination status. Findings: Of 3663 participants, 2604 (71.1%) never had Long COVID, 994 (27.1%) reported current Long COVID, and 65 (1.8%) reported resolved Long COVID. Compared to never having Long COVID, current Long COVID had lower/worse scores for Patient-Reported Outcomes Measurement Information System (PROMIS) version 29 Physical (7.8; 95% confidence interval [CI] 7.3-8.3) and Mental Health (9.4; 95% CI 8.8-10.1) and higher likelihood of moderate-to-high stress (adjusted odds ratio [aOR]: 2.0; 95% CI 1.6-2.4), moderate-to-high loneliness (aOR: 1.6; 95% CI 1.4-2.0), moderate-to-severe fatigue (aOR: 3.0; 95% CI 2.5-3.7), insufficient activity (aOR for Speedy Nutrition and Physical Activity Assessment ≤4: 0.6; 95% CI 0.5-0.7; aOR for Exercise Vital Sign ≤150 min/week: 0.7, 95% CI 0.6-1.0), and worse dyspnea (aOR: 5.0; 95% CI 4.3-5.8). Resolved Long COVID had lower scores for PROMIS Physical by 2.0 (95% CI 0.2-3.8) and Mental Health by 2.3 (95% CI 0.2-4.4) than the never-had-Long COVID cohort. Number of COVID-19 vaccinations was associated with better outcomes across all measures. Interpretation: Among participants followed up to 3 years after initial infection, those with current Long COVID had worse physical and mental health outcomes. The majority of those with Long COVID did not resolve, with less than 2% having resolved Long COVID. The resolved Long COVID cohort had moderately worse physical and mental health compared with those never-having-Long COVID. COVID-19 vaccination was associated with better outcomes. Funding: Centers for Disease Control and Prevention.

Indexed as

Long COVIDMental healthPhysical healthPROMISSARS-CoV-2

Identifiers

PMID40040820
PMCPMC11875141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.